TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option
| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 28-12-2015 |
| Asset Class: Equity |
| Benchmark: NIFTY Pharma TRI |
| Expense Ratio: 2.12% As on ( 31-05-2025) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 1,231.72 Cr As on ( 30-05-2025) |
| Turn over: 0.70 |
NAV (₹):
30.6734
₹
0.22
(
0.7013%
)
as on
04-07-2025
CAGR
Since Inception -
12.45%
NIFTY Pharma TRI -
14.52%
Fund Managers
Meeta Shetty, Rajat Srivastava
Investment Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
PERFORMANCE of TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option
Scheme Performance (%) Data as on - 04-07-2025
| 1-Year Ret (%) | 3-Yrs Ret (%) | 5-Yrs Ret (%) | 10-Yrs Ret (%) | Since Launch Ret (%) | |
|---|---|---|---|---|---|
| TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option | 14.06 | 25.49 | 22.35 | - | 12.45 |
| Nifty Pharma TRI | 11.71 | 23.32 | 18.4 | 6.92 | 14.52 |
| Equity: Sectoral-Pharma and Healthcare | 17.38 | 25.94 | 22.27 | 12.78 | 17.14 |
RETURNS CALCULATOR for TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option
Growth of 10000 In SIP (Fund vs Benchmark)
Amount :
Period :
Start :
End :
Growth of 10000 In LUMPSUM (Fund vs Benchmark)
Amount :
Start :
Rolling Returns
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Key Performance and Risk Statistics of TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option
| Key Statistics | Volatility | Sharpe Ratio | Alpha | Beta | Yield to Maturity | Average Maturity |
|---|---|---|---|---|---|---|
| TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option | ||||||
| Equity: Sectoral-Pharma and Healthcare | - | - | - | - | - | - |
PEER COMPARISION
| Scheme Name | Launch Date |
1-Year Ret (%) |
2-Yrs Ret (%) |
3-Yrs Ret (%) |
5-Yrs Ret (%) |
10-Yrs Ret (%) |
|---|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Reg IDCW Reinv | 28-12-2015 | 14.06 | 29.5 | 25.49 | 22.35 | 0.0 |
| HDFC Pharma and Healthcare Fund Gr | 04-10-2023 | 27.12 | 0.0 | 0.0 | 0.0 | 0.0 |
| WhiteOak Capital Pharma and Heathcare Fund Reg Plan Gr | 06-02-2024 | 26.32 | 0.0 | 0.0 | 0.0 | 0.0 |
| UTI Healthcare Reg Gr | 05-08-2005 | 21.2 | 33.06 | 27.38 | 22.53 | 11.89 |
| ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25-07-2018 | 20.98 | 35.33 | 30.3 | 24.91 | 0.0 |
| SBI HEALTHCARE Opportunities Reg Gr | 14-07-1999 | 20.59 | 30.51 | 29.7 | 24.66 | 11.95 |
| Mirae Asset Healthcare Reg Gr | 10-07-2018 | 16.62 | 29.56 | 24.29 | 22.48 | 0.0 |
| DSP Healthcare Reg Gr | 05-11-2018 | 16.59 | 29.05 | 26.74 | 23.51 | 0.0 |
| LIC MF Healthcare Fund Reg Gr | 22-02-2019 | 16.0 | 28.21 | 21.69 | 17.66 | 0.0 |
| Kotak Healthcare Reg Gr | 11-12-2023 | 15.68 | 0.0 | 0.0 | 0.0 | 0.0 |
Asset Allocation (%)
PORTFOLIO ANALYSIS of TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option
Portfolio as on